Filed: 11/14/2024ACC: 0001398344-24-020745
π What this filing means
ESSEX WOODLANDS MANAGEMENT, INC. filed this quarterly 13FβHR report disclosing 7 equity positions with a total reported market value of $350.40M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
7
Positions
$350.40M
Total AUM (reported)
49.53M
Total Shares
Allocation by class
COM$180.07M51.4%
COM CL A$155.60M44.4%
COM NEW$14.72M4.2%
Portfolio Concentration
Top 3$334.64M95.5%
4β10$15.76M4.5%
Top 3 weight
95.5%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 49.53M
Sole
Full voting authority
49.53M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole7
Shared0
Other0
Dominant voting typeSole Β· 100.0% of voting shares
Institutional Holdings7
Rows:
MIMEDX GROUP, INC.
SOLEShares28.20M
TypeSH
Market value$166.63M
47.56%
Sole
28.20M
Shared
0.00
None
0.00
BIOVENTUS
SOLEShares13.02M
TypeSH
Market value$155.60M
44.41%
Sole
13.02M
Shared
0.00
None
0.00
EYEPOINT PHARMACEUTICALS INC
SOLEShares1.55M
TypeSH
Market value$12.40M
3.54%
Sole
1.55M
Shared
0.00
None
0.00
TELA BIO, INC.
SOLEShares4.11M
TypeSH
Market value$10.40M
2.97%
Sole
4.11M
Shared
0.00
None
0.00
REVANCE THERAPEUTICS INC
SOLEShares457.08K
TypeSH
Market value$2.37M
0.68%
Sole
457.08K
Shared
0.00
None
0.00
MEDICINOVA INC
SOLEShares1.11M
TypeSH
Market value$2.32M
0.66%
Sole
1.11M
Shared
0.00
None
0.00
VENUS CONCEPT, INC.
SOLEShares1.09M
TypeSH
Market value$664.8K
0.19%
Sole
1.09M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting β Sole | Shared | None |
|---|---|---|---|---|---|---|---|
MIMEDX GROUP, INC.SOLE | COM | 28.20M | SH | $166.63M 47.56% | 28.20M | 0.00 | 0.00 |
BIOVENTUSSOLE | COM CL A | 13.02M | SH | $155.60M 44.41% | 13.02M | 0.00 | 0.00 |
EYEPOINT PHARMACEUTICALS INCSOLE | COM NEW | 1.55M | SH | $12.40M 3.54% | 1.55M | 0.00 | 0.00 |
TELA BIO, INC.SOLE | COM | 4.11M | SH | $10.40M 2.97% | 4.11M | 0.00 | 0.00 |
REVANCE THERAPEUTICS INCSOLE | COM | 457.08K | SH | $2.37M 0.68% | 457.08K | 0.00 | 0.00 |
MEDICINOVA INCSOLE | COM NEW | 1.11M | SH | $2.32M 0.66% | 1.11M | 0.00 | 0.00 |
VENUS CONCEPT, INC.SOLE | COM | 1.09M | SH | $664.8K 0.19% | 1.09M | 0.00 | 0.00 |